Dimethyl Fumarate‐Associated Acute Hepatocellular Injury Assessed for Causality Using the Updated RUCAM: A Biopsy‐Supported Case Report

Ophir Lavon, Maram Salameh · 2026

Read Dimethyl Fumarate‐Associated Acute Hepatocellular Injury Assessed for Causality Using the Updated RUCAM: A Biopsy‐Supported Case Report by Ophir Lavon, Maram Salameh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13559025.txt.

Description

Ophir Lavon and Maram Salameh offer a 2026 case report of acute liver injury tied to dimethyl fumarate, a drug for multiple sclerosis. In a 26-year-old woman, liver enzymes rose soon after she started the drug. A liver biopsy supported drug-induced injury. A standard causality score, the updated RUCAM, gave 6, which marks probable cause, and stopping the drug fit that reading. A negative antibody test lowered the chance of autoimmune hepatitis. Hepatitis E was not tested, which left one rival cause open and kept full certainty out of reach.

Catalog record

CREATOROphir Lavon, Maram Salameh
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE15 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13559025

Browse the full library · About the Tower of Babel